Focus
View

Apellis Pharmaceuticals, Inc.

APLS · FY2025

MIXED

CEO Package

$13.3M

Pay Ratio

—

Cedric Francois

Awaiting a fuller pay-performance history

ELI LILLY & Co

LLY · FY2025

MIXED

CEO Package

$36.7M

Pay Ratio

—

David A. Ricks

Pay and TSR both rose, but not in lockstep

JOHNSON & JOHNSON

JNJ · FY2025

ALIGNED

CEO Package

$32.8M

Pay Ratio

—

Joaquin Duato

Returns outran pay growth by +16.0 pts

CEOTotal Compensation — All Companies

APLS$13.3MLLY$36.7MJNJ$32.8M

All values are grant-date fair value as reported in proxy statements.

Key Differences

The fastest way to read this comparison before dropping into the tables.

LLY carries the largest package at $36.7M, about 2.8x APLS.
APLS reads mixed, while JNJ looks aligned.

Pay Component Breakdown

Latest CEO package mix by company. This stays on the CEO package even if the chart above is showing Top 5 pay.

APLS

Cedric Francois

$13.3M

base salary6%
stock awards73%
option awards18%
other compensation0%

LLY

David A. Ricks

$36.7M

base salary5%
stock awards64%
non-equity incentive compensation18%
other compensation2%

JNJ

Joaquin Duato

$32.8M

base salary5%
stock awards46%
option awards18%
non-equity incentive compensation13%
other compensation2%

Quick Comparison

CompanyCEOLatest YearTotal Comp
Apellis Pharmaceuticals, Inc.(APLS)Cedric Francois2025$13.3M
ELI LILLY & Co(LLY)David A. Ricks2025$36.7M
JOHNSON & JOHNSON(JNJ)Joaquin Duato2025$32.8M

Note: All compensation values shown are grant-date fair value as reported in proxy statements. Direct comparisons should account for differences in company size, industry, and compensation structure.

Want to know when these numbers change?

We’ll email you when these companies file a new proxy — so you can see how CEO pay, equity awards, and ratios shift before the next headline.